Dozee contactless heart rate and breathing rate validation in clinical settings
Official title: Dozee System Validation for Contactless Heart Rate and Respiration Monitoring in Clinical Settings
Run by Turtle Shell Technologies Pvt. Ltd. · NCT07735403 · Data updated 2026-11-12
This study tests updated AI-powered heart rate and breathing rate algorithms for a contactless under-mat monitor in adults to see if it accurately tracks vital signs.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 22 Years to 100 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Turtle Shell Technologies Pvt. Ltd. Industry-sponsored |
| Locations | 1 site (Lake Jackson, Texas) |
| Status | Recruiting |
| Started | July 15, 2026 |
| Main results expected | December 15, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | September 21, 2026 |
| Trial ID | NCT07735403 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 22 and older who can consent and weigh more than 40 kg, without devices or conditions that interfere with monitoring at the bedside.
✕Probably not a fit
Patients with conditions or treatments that interfere with device monitoring or require procedures during the testing period may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study evaluates the Dozee VS system, a non-invasive device placed under a mattress to monitor heart rate and breathing rate using body-signal vibrations. It compares the Gen 2 AI-powered HR and improved RR algorithms across three sensor sheet types (DS, S1, S1-I) to standard clinical accuracy benchmarks. Telemetry monitoring is used to collect real-time vital signs and evaluate performance alongside optional add-ons like blood pressure, oximetry, and thermometry. The study aims to confirm accuracy and reliability of the updated software and hardware across diverse mattress types and patient characteristics. The investigation is conducted at a single site with adults enrolled per the inclusion and exclusion criteria specified by the sponsor.
Why it matters
Potential benefit: If successful, the device could provide accurate, non-contact vital signs with remote monitoring capabilities, potentially improving patient comfort and early detection of deterioration.
How similar studies have gone: Prior work with similar contactless monitoring approaches has shown potential, though this study tests updated AI algorithms and multiple sensor sheet types for broader validation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults Male or female. (≥ 22 years of age) * Provide written informed consent. * Weight over 40kg/88.18lbs Exclusion Criteria: * Are connected to a device that may interfere with the device monitoring in this study. * Are receiving any bedside care which may be incompatible with the study procedures. * A likely need to receive or undergo a procedure during the testing period. * Cannot accept a nasal cannula, or have an ECG leads placed on the chest. * Have a significant medical condition in the judgement of the investigator, which may compromise the study testing procedures. * Prisoners
Where it's running
-
Oak Village Healthcare
Lake Jackson, Texas, United States Recruiting
Study contacts
- Principal investigator: Lindsay Darthard, LVN LNFA — Oak Village Healthcare
- Study coordinator: Lindsay Darthard, LVN LNFA
- Email: lindsaydarthard@gcltc.com
- Phone: 979-297-0425
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.